Helicobacter pylori strain MGms23

Helicobacter pylori strain MGms23 is a microaerophilic, Gram-negative bacterium classified as a spirilla. It typically exists as single cells and possesses flagella, allowing for motility despite its free-living biotic relationship. This strain is mesophilic, with an optimal growth temperature of 37°C, and it has a unique cellular structure characterized by two membranes and a single replicon. Helicobacter pylori is notably associated with various hosts, including Homo sapiens, Gallus gallus, Aves, Primates, Mammalia, Amoeba, Rodentia, and Cricetinae. The bacterium is well-documented for its pathogenicity in humans, contributing to a range of gastrointestinal diseases. These include chronic gastric inflammation, peptic ulcer disease, and various forms of gastric cancer, such as gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma. Other health effects linked to this strain include chronic gastritis, dyspepsia, functional dyspepsia, and acute gastric ulcers. Ecologically, H. pylori strain MGms23 plays a significant role in the human microbiome, influencing gastric health and disease. Its presence can lead to both symptomatic conditions and asymptomatic mucosal inflammatory responses, highlighting its complex interactions within host organisms. The strain's ability to thrive in various hosts suggests an adaptable ecological niche, impacting health outcomes across different species. Understanding the traits and effects of H. pylori MGms23 is crucial for addressing its implications in human health, particularly concerning gastrointestinal diseases.